Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Baird raised the price target for Tesla, Inc. TSLA from $280 to $480. Baird analyst Ben Kallo maintained an Outperform rating. Tesla shares closed at $479.86 on Tuesday. See how other analysts view this stock.
- Truist Securities raised the price target for Community Healthcare Trust Incorporated CHCT from $22 to $23. Truist Securities analyst Michael Lewis maintained a Buy rating. Community Healthcare Trust shares closed at $18.85 on Tuesday. See how other analysts view this stock.
- Wells Fargo boosted the price target for Targa Resources Corp. TRGP from $190 to $204. Wells Fargo analyst Michael Blum maintained an Overweight rating. Targa Resources shares closed at $181.22 on Tuesday. See how other analysts view this stock.
- JMP Securities cut Bicycle Therapeutics plc BCYC price target from $32 to $26. JMP Securities analyst Reni Benjamin maintained a Market Outperform rating. Bicycle Therapeutics shares settled at $15.14 on Tuesday. See how other analysts view this stock.
- Cantor Fitzgerald raised Archer Aviation Inc. ACHR price target from $10 to $13. Cantor Fitzgerald analyst Andres Sheppard maintained an Overweight rating. Archer Aviation shares closed at $9.09 on Tuesday. See how other analysts view this stock.
- Morgan Stanley boosted Zoom Communications Inc. ZM price target from $86 to $96. Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating. Zoom Communications shares closed at $84.60 on Tuesday. See how other analysts view this stock.
- Alliance Global Partners raised Vitesse Energy, Inc. VTS price target from $26 to $29. Alliance Global Partners analyst Jeff Grampp upgraded the stock from Neutral to Buy. Vitesse Energy shares closed at $26.19 on Tuesday. See how other analysts view this stock.
- B of A Securities cut the price target for 4D Molecular Therapeutics, Inc. FDMT from $79 to $46. B of A Securities analyst Tazeen Ahmad maintained a Buy rating. 4D Molecular Therapeutics shares settled at $6.32 on Tuesday. See how other analysts view this stock.
- JP Morgan raised Amazon.com, Inc. AMZN price target from $250 to $280. JP Morgan analyst Doug Anmuth maintained an Overweight rating. Amazon shares closed at $231.15 on Tuesday. See how other analysts view this stock.
- JP Morgan increased Alphabet Inc. GOOGL price target from $212 to $232. JP Morgan analyst Doug Anmuth maintained an Overweight rating. Alphabet shares closed at $195.42 on Tuesday. See how other analysts view this stock.
Considering buying AMZN stock? Here’s what analysts think:
Read This Next:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
